glp 1 blind ATLANTA GLP-1 Size Curve Report 2025

Marti-Aguado D, Calleja JL, Vilar-Gomez E, Iruzubieta P, Rodrguez-Duque JC, Del Barrio M, Puchades L, Rivera-Esteban J, Perell C, Puente A, Gomez-Medina C, Escudero-Garca D, Serra MA, Bataller R, Crespo J, Arias-Loste MT

These typically improve over time, especially with gradual dose escalation

However, the proportion of patients referred to a health care facility increased from 23% to 33.5% over the study period.The authors say many of these errors were preventable and could be reduced through better patient education.The findings were recently published in the Journal of Medical Toxicology.More informationAmerica's Poison Centers has more on GLP-1s and overdose.SOURCE: HealthDay TV, June 25, 2026 .What This Means For YouAs GLP-1 weight-loss drugs become more popular, medication mistakes are becoming more common, underscoring the need for clearer instructions and patient education..Sign up for our weekly HealthDay newsletter

Now, the question is whether another wave of disruption is poised to impact foodservice

Semaglutide is unique in its once-weekly dosing option for both diabetes management and weight loss, offering convenience and potentially improved adherence compared to other GLP-1 receptor agonists